Phase 2 Trial of LACTIN-V in Women at High Risk of HIV Acquisition

NCT05022212 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Bacterial Vaginosis
HIV Infections

Interventions

DRUG: LACTIN-V
DRUG: Placebo

Sponsor

University of California, San Francisco

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]